BridgeBio Pharma

Develops drugs for rare genetic conditions, including ATTR amyloidosis, achondroplasia and muscular dystrophy

+ Add to sales board

Highlights

  • GrowingRevenue +126% YoY (FY2025)
  • Hiring20 open roles
  • Remote-friendly16 of 20 open roles remote or hybrid

About BridgeBio Pharma

BridgeBio Pharma Inc. is a biopharmaceutical company developing medicines for genetic conditions. Its pipeline includes acoramidis for variant transthyretin amyloidosis, BBP-418 for limb-girdle muscular dystrophy type 2I/R9, encaleret for autosomal dominant hypocalcemia type 1, infigratinib for achondroplasia and hypochondroplasia, and BBP-812 for Canavan disease.

The company works with a hub-and-spoke model in which focused teams concentrate on a specific condition or drug candidate, supported by a central hub with clinical, regulatory and commercial capabilities. It partners with academic institutions on research. Its stated audience is people living with genetic conditions, and its affiliate BridgeBio Oncology Therapeutics develops small molecule inhibitors for RAS- and PI3Kα-driven cancers.

The website reports more than 2000 patients enrolled in clinical trials globally and three FDA approvals received. Offices are listed in San Francisco and Palo Alto, California, and Zug, Switzerland, and open roles also reference Germany, France, Portugal and the Netherlands. The company has 40 open positions, mainly in commercial, medical affairs, market access, manufacturing and clinical operations.

Product: Investigational and approved therapeutics for genetic conditions, including acoramidis, infigratinib and encaleret.

Jobs at BridgeBio Pharma (20)

BridgeBio Pharma is hiring for 20 roles, mostly in operations, based in Zug. 4 are remote.

See all 20 jobs at BridgeBio Pharma →

Companies hiring like BridgeBio Pharma

More biotech & pharma companies

  • Bristolmyerssquibb

    Biopharmaceutical company developing prescription medicines for serious diseases in oncology, hematology and neuroscience
    New York, United StatesBiotech & pharma86 open jobs
    New on Evolc
  • Calyx

    Clinical trial imaging, RTSM and eClinical services for biopharma sponsors and CROs running preclinical and clinical studies
    United StatesBiotech & pharma3 open jobs
    New on EvolcRemote-friendly
  • Corcept Therapeutics

    Develops cortisol-modulating medicines for patients with serious diseases
    United StatesBiotech & pharma2 open jobs
  • Countable Labs

    Single-molecule PCR instruments, assays and testing services for genomics and life-science researchers
    Palo Alto, United StatesBiotech & pharma1 open job
    Remote-friendly
  • Drug Hunter

    Drug discovery intelligence platform for medicinal chemists, biologists and project leaders in pharma and biotech
    United StatesBiotech & pharma1 open job
    New on EvolcRemote-friendly
  • Gilead

    CAR T-cell cancer therapies for patients with blood cancers, developed by Kite, a Gilead company
    United StatesBiotech & pharma5 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • AWS
  • Contentful
  • Google Tag Manager
  • Greenhouse
  • OneTrust
  • Optimizely
  • Sanity